Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBPP) Other financing activities (2016 - 2017)

Historic Other financing activities for Regen BioPharma (RGBPP) over the last 4 years, with Q1 2017 value amounting to $3340.0.

  • Regen BioPharma's Other financing activities fell 9865.18% to $3340.0 in Q1 2017 from the same period last year, while for Sep 2017 it was $8580.0, marking a year-over-year decrease of 9899.04%. This contributed to the annual value of $8580.0 for FY2017, which is 9899.04% down from last year.
  • Per Regen BioPharma's latest filing, its Other financing activities stood at $3340.0 for Q1 2017, which was down 9865.18% from $5240.0 recorded in Q4 2016.
  • In the past 5 years, Regen BioPharma's Other financing activities ranged from a high of $485097.0 in Q3 2014 and a low of $3340.0 during Q1 2017
  • Over the past 4 years, Regen BioPharma's median Other financing activities value was $247587.5 (recorded in 2015), while the average stood at $197132.1.
  • As far as peak fluctuations go, Regen BioPharma's Other financing activities surged by 8682.76% in 2016, and later plummeted by 9865.18% in 2017.
  • Quarter analysis of 4 years shows Regen BioPharma's Other financing activities stood at $485097.0 in 2014, then plummeted by 48.93% to $247723.0 in 2015, then tumbled by 97.88% to $5240.0 in 2016, then crashed by 36.26% to $3340.0 in 2017.
  • Its Other financing activities stands at $3340.0 for Q1 2017, versus $5240.0 for Q4 2016 and $106665.0 for Q3 2016.